We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOW icon
126
Lowe's Companies
LOW
$116B
$14.4M 0.18%
131,149
+8,300
+7% +$828K
APD icon
127
Air Products & Chemicals
APD
$66.3B
$14.3M 0.18%
69,065
-36,273
-34% -$6.24M
ZBH icon
128
Zimmer Biomet
ZBH
$17.7B
$14.2M 0.18%
114,822
+15,483
+16% +$1.76M
TRV icon
129
Travelers Companies
TRV
$80.8B
$14.1M 0.18%
95,861
-15,243
-14% -$1.95M
BDX icon
130
Becton Dickinson
BDX
$43.1B
$14M 0.18%
57,431
-707
-1% -$167K
LUV icon
131
Southwest Airlines
LUV
$22.1B
$13.9M 0.18%
268,701
+74,358
+38% +$3.92M
ANET icon
132
Arista Networks
ANET
$219B
$13.7M 0.18%
696,176
-656,960
-49% -$10.4M
ZION icon
133
Zions Bancorporation
ZION
$10.1B
$13.4M 0.17%
296,158
+54,438
+23% +$2.6M
SCCO icon
134
Southern Copper
SCCO
$141B
$13.4M 0.17%
+364,605
New +$11.6M
NEM icon
135
Newmont
NEM
$98.2B
$13.4M 0.17%
374,086
+132,815
+55% +$4.5M
MCHP icon
136
Microchip Technology
MCHP
$42.8B
$13.4M 0.17%
322,280
+161,386
+100% +$6.69M
MCD icon
137
McDonald's
MCD
$188B
$13.3M 0.17%
70,037
-3,878
-5% -$704K
HIG icon
138
Hartford Financial Services
HIG
$38.5B
$13.3M 0.17%
266,743
+79,089
+42% +$3.76M
BIO icon
139
Bio-Rad Laboratories Class A
BIO
$8.42B
$13.2M 0.17%
43,290
– –
WM icon
140
Waste Management
WM
$95.9B
$13.2M 0.17%
101,325
-1,446
-1% -$141K
WP
141
DELISTED
Worldpay, Inc.
WP
$13.2M 0.17%
116,124
+98,682
+566% +$8.95M
CBAY
142
DELISTED
Cymabay Therapeutics
CBAY
$13M 0.17%
978,000
– –
SPR
143
DELISTED
Spirit AeroSystems
SPR
$13M 0.17%
141,797
+38,942
+38% +$3.44M
DVN icon
144
Devon Energy
DVN
$51.9B
$13M 0.17%
410,860
+226,562
+123% +$6.33M
ZGNX
145
DELISTED
Zogenix, Inc.
ZGNX
$13M 0.17%
235,700
– –
HON icon
146
Honeywell
HON
$77.1B
$12.7M 0.16%
85,089
+1,594
+2% +$223K
NEE icon
147
NextEra Energy
NEE
$187B
$12.7M 0.16%
226,900
+9,840
+5% +$450K
SYK icon
148
Stryker
SYK
$127B
$12.7M 0.16%
64,272
+576
+0.9% +$104K
ARNA
149
DELISTED
Arena Pharmaceuticals Inc
ARNA
$12.7M 0.16%
282,800
+5,000
+2% +$229K
CNP icon
150
CenterPoint Energy
CNP
$29.1B
$12.6M 0.16%
371,801
+60,331
+19% +$1.82M
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.